Lifevantage Debt to Equity Ratio 2012-2026 | LFVN
Current and historical debt to equity ratio values for Lifevantage (LFVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lifevantage debt/equity for the three months ending June 30, 2026 was 0.00.
| Lifevantage Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $0.03B | $0.03B | 0.85 |
| 2026-03-31 | $0.03B | $0.03B | 0.86 |
| 2025-12-31 | $0.03B | $0.03B | 0.85 |
| 2025-09-30 | $0.03B | $0.03B | 0.86 |
| 2025-06-30 | $0.04B | $0.04B | 1.08 |
| 2025-03-31 | $0.04B | $0.03B | 1.27 |
| 2024-12-31 | $0.04B | $0.03B | 1.29 |
| 2024-09-30 | $0.03B | $0.03B | 1.22 |
| 2024-06-30 | $0.03B | $0.03B | 1.32 |
| 2024-03-31 | $0.04B | $0.03B | 1.29 |
| 2023-12-31 | $0.04B | $0.03B | 1.30 |
| 2023-09-30 | $0.04B | $0.03B | 1.27 |
| 2023-06-30 | $0.03B | $0.04B | 0.91 |
| 2023-03-31 | $0.03B | $0.03B | 1.01 |
| 2022-12-31 | $0.04B | $0.03B | 1.13 |
| 2022-09-30 | $0.04B | $0.03B | 1.12 |
| 2022-06-30 | $0.04B | $0.03B | 1.24 |
| 2022-03-31 | $0.04B | $0.03B | 1.12 |
| 2021-12-31 | $0.04B | $0.04B | 1.08 |
| 2021-09-30 | $0.04B | $0.04B | 1.03 |
| 2021-06-30 | $0.04B | $0.04B | 1.14 |
| 2021-03-31 | $0.04B | $0.04B | 1.11 |
| 2020-12-31 | $0.04B | $0.04B | 1.10 |
| 2020-09-30 | $0.04B | $0.03B | 1.06 |
| 2020-06-30 | $0.03B | $0.03B | 0.77 |
| 2020-03-31 | $0.02B | $0.03B | 0.83 |
| 2019-12-31 | $0.03B | $0.03B | 0.89 |
| 2019-09-30 | $0.03B | $0.03B | 0.89 |
| 2019-06-30 | $0.03B | $0.03B | 1.03 |
| 2019-03-31 | $0.03B | $0.03B | 1.19 |
| 2018-12-31 | $0.03B | $0.02B | 1.57 |
| 2018-09-30 | $0.03B | $0.02B | 1.21 |
| 2018-06-30 | $0.03B | $0.02B | 1.33 |
| 2018-03-31 | $0.03B | $0.02B | 1.64 |
| 2017-12-31 | $0.03B | $0.02B | 1.77 |
| 2017-09-30 | $0.03B | $0.02B | 1.84 |
| 2017-06-30 | $0.03B | $0.02B | 2.12 |
| 2017-03-31 | $0.03B | $0.01B | 2.36 |
| 2016-12-31 | $0.03B | $0.02B | 2.21 |
| 2016-09-30 | $0.04B | $0.01B | 2.54 |
| 2016-06-30 | $0.04B | $0.01B | 3.78 |
| 2016-03-31 | $0.04B | $0.01B | 3.99 |
| 2015-12-31 | $0.04B | $0.01B | 5.41 |
| 2015-09-30 | $0.04B | $0.01B | 7.65 |
| 2015-06-30 | $0.04B | $0.00B | 10.96 |
| 2015-03-31 | $0.04B | $0.00B | 15.58 |
| 2014-12-31 | $0.05B | $0.01B | 10.23 |
| 2014-09-30 | $0.05B | $0.01B | 6.88 |
| 2014-06-30 | $0.05B | $0.00B | 12.53 |
| 2014-03-31 | $0.07B | $0.00B | 24.78 |
| 2013-12-31 | $0.06B | $0.00B | -116.68 |
| 2013-09-30 | $0.02B | $0.04B | 0.55 |
| 2013-06-30 | $0.02B | $0.03B | 0.64 |
| 2013-03-31 | $0.02B | $0.04B | 0.56 |
| 2012-12-31 | $0.02B | $0.04B | 0.57 |
| 2012-09-30 | $0.02B | $0.03B | 0.47 |
| 2012-06-30 | $0.02B | $0.03B | 0.57 |
| 2012-03-31 | $0.01B | $0.02B | 0.48 |
| 2011-12-31 | $0.02B | $0.01B | 1.64 |
| 2011-09-30 | $0.03B | $-0.02B | -2.06 |
| 2011-06-30 | $0.03B | $-0.02B | -1.60 |
| 2011-03-31 | $0.02B | $-0.01B | -1.73 |
| 2010-12-31 | $0.01B | $-0.01B | -2.63 |
| 2010-09-30 | $0.02B | $-0.01B | -1.61 |
| 2010-06-30 | $0.02B | $-0.02B | -1.39 |
| 2010-03-31 | $0.02B | $-0.01B | -1.50 |
| 2009-12-31 | $0.01B | $-0.01B | -1.88 |
| 2009-09-30 | $0.01B | $-0.01B | -1.86 |
| 2009-06-30 | $0.01B | $-0.01B | -1.84 |
| 2009-03-31 | $0.01B | $0.00B | -2.35 |
| 2008-12-31 | $0.00B | $0.00B | 0.39 |
| 2008-09-30 | $0.00B | $0.00B | 0.33 |
| 2008-06-30 | $0.00B | $0.00B | 0.44 |
| 2008-03-31 | $0.00B | $0.00B | 0.52 |
| 2007-12-31 | $0.00B | $0.00B | 0.39 |
| 2007-09-30 | $0.00B | $0.00B | 0.44 |
| 2007-06-30 | $0.00B | $0.00B | 0.44 |
| 2007-03-31 | $0.00B | $0.00B | 0.51 |
| 2006-12-31 | $0.00B | $0.00B | 0.70 |
| 2006-09-30 | $0.00B | $0.01B | 0.52 |
| 2006-06-30 | $0.00B | $0.01B | 0.26 |
| 2006-03-31 | $0.00B | $0.01B | 0.23 |
| 2005-12-31 | $0.00B | $0.01B | 0.17 |
| 2005-09-30 | $0.00B | $0.01B | 0.14 |
| 2005-06-30 | $0.00B | $0.01B | 0.08 |
| 2005-03-31 | $0.00B | $0.00B | 2.61 |
| 2004-12-31 | $0.00B | $0.00B | -1.45 |
| 2004-09-30 | $0.00B | $0.00B | -2.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.077B | $0.183B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |